SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
Abstract SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered a novel immune modulatory function of SHP2. Targeting this protein with allosteric SHP2 inhibitors promoted anti-tumor immunity, including enhancing T cell cyt...
Guardado en:
Ejemplares similares
-
TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts
por: Angelo L. Grauel, et al.
Publicado: (2020) -
Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an MYCN Amplified Neuroblastoma Tumor
por: Orienti I, et al.
Publicado: (2020) -
Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes
por: Chen R, et al.
Publicado: (2020) -
Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer
por: Shao-Yuan Chen, et al.
Publicado: (2021) -
The tumor therapy landscape of synthetic lethality
por: Biyu Zhang, et al.
Publicado: (2021)